Ning Li, M.D., Ph.D., Chairman of the Board

  • Oversee Junshi Biosciences overseas business activities.
  • Former Vice President and Head of Region Asia Regulatory Affairs and Medical Policy at Sanofi.
  • Former Regulatory Reviewer/Senior Reviewer of Oncology Division and Team Leader and Branch Chief at FDA.
  • B.S. in Medicine and M.D. from Shanghai Medical College of Fudan University and Ph.D. in Preventive Medicine from University of Iowa.

Sheng Yao, Ph.D., Chief Executive Officer and Executive Director

  • Co-founder of Shanghai Junshi Pharma and TopAlliance Biosciences.
  • Research fellow in immunology at the Mayo Clinic College of Medicine and Johns Hopkins University.
  • Trained under the guidance of immunotherapy pioneer, Dr. Lieping Chen.
  • B.S. Biotechnology from Peking University and Ph.D. from Albert Einstein College of Medicine.

Patricia Keegan ,M.D., Chief Medical Officer

  • Former Acting Associate Director of Medical Policy Oncology Center for Excellence (OCE), Office of the Commissioner.
  • Division Director of Oncology Products (16 years).
  • Deputy Director Division of Clinical Trial Design and Analysis (4 years).
  • Chief and Medical Officer at Oncology Branch (8 years)
  • Clinical Assistance Professor and Medical Oncologist at University of North Carolina at Chapel Hill.
  • B.S. in Biology from University of Illinois Champaign-Urbana and M.D. from Loyola University Stritch School of Medicine
  • Completed her residency in internal medicine at the Loyola University Medical Center, Maywood, Illinois, and her fellowship in medical oncology at Roswell Park Memorial Institute, Buffalo, New York

Kevin Li, Ph.D., Vice President of Regulatory Affairs

  • Joined TopAlliance since 2020.
  • Oversee the all regulatory-related activities.
  • Former Director of Regulatory Affairs at AstraZeneca BioVentures and Head of Regulatory Affairs at Centus Biotherapeutics.
  • Former Product Quality Reviewer at the Office of Biotechnology Products (OBP) and the Office of Life Cycle Product at CDER/FDA.
  • B.S. in Biotechnology from Peking University and Ph.D. from University of Illinois at Urbana-Champaign.

Monica Hughes, Vice President of Project and Portfolio Management

  • Responsible for developing and executing the clinical portfolio/project management strategies on behalf of the CMO
  • Industry Executive Leadership roles in Regulatory Affairs and Project Management (3 years)
  • Chief, Project Management Staff for the Division of Oncology Products 2 in the Office of Oncologic Diseases, CDER, US FDA (8 years)
  • Regulatory Project Manager/Team Leader for the Division of Oncology Products 2 in the Office of Oncologic Diseases, CDER, US FDA (10 years)
  • B.S. in Combined Science Biology/Chemistry and M.S. in Molecular Biology from Youngstown State University